⌘K

Login Start Free

Home/Filings/4/0001641172-25-003951

4//SEC Filing

Agah Ramtin 4

Accession 0001641172-25-003951

CIK 0001574094other

View on SEC.gov Company Profile

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 6:30 AM ET

Size

4.7 KB

Accession

0001641172-25-003951

Insider Transaction Report

Form 4

Period: 2025-04-11

RenovoRx, Inc.RNXT

DirectorChief Medical Officer

Transactions

Purchase
Common Stock
2025-04-11$0.80/sh+20,000$16,000→ 1,098,460 total

Footnotes (1)

[F1]Reflects open market purchases of the Issuer's securities.

Documents

1 file

4
ownership.xmlPrimary

Issuer

RenovoRx, Inc.

CIK 0001574094

Entity typeother

Related Parties

1

filerCIK 0001862617

Filing Metadata

Form type: 4
Filed: Apr 13, 8:00 PM ET
Accepted: Apr 14, 6:30 AM ET
Size: 4.7 KB

View on SEC.gov